Details for New Drug Application (NDA): 063221
✉ Email this page to a colleague
NDA 063221 describes CEFTAZIDIME SODIUM IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. Additional details are available on the CEFTAZIDIME SODIUM IN PLASTIC CONTAINER profile page.
The generic ingredient in CEFTAZIDIME SODIUM IN PLASTIC CONTAINER is ceftazidime sodium. There are seventeen drug master file entries for this compound. Additional details are available on the ceftazidime sodium profile page.
The generic ingredient in CEFTAZIDIME SODIUM IN PLASTIC CONTAINER is ceftazidime sodium. There are seventeen drug master file entries for this compound. Additional details are available on the ceftazidime sodium profile page.
Summary for 063221
| Tradename: | CEFTAZIDIME SODIUM IN PLASTIC CONTAINER |
| Applicant: | Baxter Hlthcare |
| Ingredient: | ceftazidime sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/ML | ||||
| Approval Date: | Apr 29, 1993 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 20MG BASE/ML | ||||
| Approval Date: | Apr 29, 1993 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 40MG BASE/ML | ||||
| Approval Date: | Apr 29, 1993 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
